68Ga-DOTATATE PET/CT 较对比增强 MRI 提高经骨脑膜瘤检测
本回顾性研究纳入82例病理确诊脑膜瘤患者,比较68Ga-DOTATATE PET/CT与对比增强MRI检测骨侵犯的诊断效能。PET/CT灵敏度98.5% vs CE-MRI 53.7%,特异度86.7% vs 93.3%,曲线下面积0.932 vs 0.773。结论:PET/CT较CE-MRI提高经骨延伸检测。
要点
- 经骨延伸组(n=67)较骨外组(n=15)病灶更大(中位12.8 vs 3.3 mL,P<0.001)、SUVmax更高(中位14.2 vs 7.6,P=0.011)。
- PET/CT检测骨侵犯灵敏度98.5% vs CE-MRI 53.7%,特异度86.7% vs 93.3%(P<0.001)。
- ROC分析PET/CT评估优于CE-MRI(曲线下面积0.932 vs 0.773)。
核心结论
- 68Ga-DOTATATE PET/CT较对比增强MRI提高颅内脑膜瘤经骨延伸的检测。
研究设计与样本
- 本机构审查委员会批准的回顾性研究,从327例连续68Ga-DOTATATE PET/CT检查中筛选受试者,纳入标准为30天内行CE-MRI且有病理确诊脑膜瘤并以纳入或排除经骨延伸为参考标准。
- 共82例患者符合纳入标准,由两名阅片者分析影像,测定示踪剂摄取值和脑膜瘤体积。
主要发现
- 经骨延伸组(n=67)较骨外脑膜瘤组(n=15)病灶更大(中位12.8 vs 3.3 mL,P<0.001)、示踪剂摄取更高(中位SUVmax 14.2 vs 7.6,P=0.011)。
- PET/CT检测骨侵犯灵敏度98.5% vs CE-MRI 53.7%,特异度86.7% vs 93.3%(P<0.001)。
- ROC分析中PET/CT评估优于CE-MRI(曲线下面积0.932 vs 0.773)。
- PET/CT与CE-MRI体积估计在骨外脑膜瘤(P=0.132)和经骨脑膜瘤骨外部分(P=0.636)结果相当,而骨内部分体积PET/CT评估显著更大(P<0.001)。
关键数值与推荐
- 经骨延伸组中位SUVmax 14.2 vs 骨外组7.6(P=0.011)。
- PET/CT检测骨侵犯灵敏度98.5% vs CE-MRI 53.7%,特异度86.7% vs 93.3%(P<0.001)。
- PET/CT曲线下面积0.932 vs CE-MRI 0.773。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
68Ga-DOTATATE PET/CT enables detection of meningioma tissue based on somatostatin receptor 2 expression. Transosseous extension of intracranial meningiomas is known to be an important risk factor for tumor recurrence and patient mortality. We analyzed the diagnostic performance of 68Ga-DOTATATE PET/CT and contrast-enhanced MRI (CE-MRI) for the detection of osseous infiltration using qualitative and quantitative imaging parameters. Methods: In this institutional review board-approved retrospective study, subjects were selected from 327 consecutive 68Ga-DOTATATE PET/CT examinations for evaluation of confirmed or suspected meningioma. Inclusion criteria were CE-MRI within 30 d and pathology-confirmed meningioma diagnosis with inclusion or exclusion of transosseous extension as the standard of reference. Imaging was analyzed by two readers. Tracer uptake values and meningioma volumes were determined. χ2, Mann-Whitney U, Wilcoxon signed rank, and McNemar tests, as well as receiver-operating-characteristic analyses, were performed to compare variables and diagnostic performance. Results: Eighty-two patients fulfilled the inclusion criteria. Patients with transosseous extension of meningioma (n = 67) showed significantly larger lesions (median, 12.8 vs. 3.3 mL; P < 0.001) and significantly higher tracer uptake values (median SUVmax, 14.2 vs. 7.6; P = 0.011) than patients with extraosseous meningiomas (n = 15). 68Ga-DOTATATE PET/CT in comparison to CE-MRI performed at a higher sensitivity (98.5% vs. 53.7%) while maintaining high specificity (86.7% vs. 93.3%) in the detection of osseous involvement (P < 0.001). In receiver-operating-characteristic analysis, PET/CT assessment performed better than CE-MRI (area under the curve, 0.932 vs. 0.773). PET/CT- and CE-MRI-based volume estimation yielded comparable results for extraosseous meningiomas (P = 0.132) and the extraosseous part of transosseous meningiomas (P = 0.636), whereas the volume of the intraosseous part was assessed as significantly larger by PET/CT (P < 0.001). Conclusion:68Ga-DOTATATE PET/CT enables improved detection of the transosseous extension of intracranial meningiomas compared with CE-MRI.
引用
- Kunz WG, Jungblut LM, Kazmierczak PM, et al. Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI. J Nucl Med. 2017. PMID: 28450556. doi:10.2967/jnumed.117.191932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。